SCHEMBL27664207

SCHEMBL27664207

CC(C)(C)OC(N)=O.Cc1cnc(Cl)cc1I

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
SIRT6 Q8N6T7 1/20 0.33
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32
AAK1 Q2M2I8 2/20 0.32
TRPA1 O75762 1/20 0.32
SLC2A1 P11166 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
NNMT P40261 1/20 0.31
STK17B O94768 1/20 0.31
STK17A Q9UEE5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30335232 0.78
SCHEMBL11901055 0.78
SCHEMBL27520742 0.77 PLA2G7 (0.40) KMT2AAAK1HPGDPOLB
SCHEMBL20850921 0.76 ATR (0.39) CA12CA1CA2CA9LMNA
SCHEMBL27643013 0.75 CYP3A4 (0.32) CNR2SIRT6LMNA
SCHEMBL27664204 0.75 CNR2 (0.32) CNR2SIRT6LMNAKMT2ATRPA1
SCHEMBL31006692 0.75 GABRG2 (0.39) CNR2CA12CA1CA2CA9
SCHEMBL27762743 0.75 AAK1 (0.39) CA12CA1CA2CA9LMNA
SCHEMBL29364468 0.72 ATR (0.42) CNR2AAK1TRPA1STK17BSTK17A
SCHEMBL15584205 0.72 ATR (0.42) CNR2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101379034-B Benzamide and heteroarene derivatives as CETP inhibitors F. HOFFMANN-LA ROCHE AG (CH) 2011-12-28 CN disclosed
CN-1852712-B Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE 2010-06-09 CN disclosed
CN-101035533-B Dual NK1/NK3 antagonists against schizophrenia HOFFMANN LA ROCHE 2010-05-05 CN disclosed
CN-101379034-A Benzamide and heteroarene derivatives as CETP inhibitors HOFFMANN LA ROCHE (CH) 2009-03-04 CN disclosed
CN-101035533-A Dual NK1/NK3 antagonists against schizophrenia HOFFMANN LA ROCHE (CH) 2007-09-12 CN disclosed
CN-1852712-A Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE (CH) 2006-10-25 CN disclosed